Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orthofix Medical (OFIX) Debt to Equity (2018 - 2026)

Orthofix Medical has reported Debt to Equity over the past 14 years, most recently at $0.51 for Q1 2026.

  • For the quarter ending Q1 2026, Debt to Equity rose 48.57% year-over-year to $0.51, compared with a TTM value of $0.51 through Mar 2026, up 48.57%, and an annual FY2025 reading of $0.35, up 7.22% over the prior year.
  • Debt to Equity came in at $0.51 for Q1 2026, up from $0.35 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.51 in Q1 2026 to a low of $0.0 in Q4 2022.
  • Median Debt to Equity over the past 5 years was $0.22 (2024), compared with a mean of $0.24.
  • The sharpest move saw Debt to Equity tumbled 94.18% in 2022, then surged 5208.75% in 2023.
  • Over 5 years, Debt to Equity stood at $0.0 in 2022, then surged by 5208.75% to $0.16 in 2023, then surged by 106.98% to $0.33 in 2024, then increased by 7.22% to $0.35 in 2025, then surged by 45.43% to $0.51 in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Debt to Equity are $0.51 (Q1 2026), $0.35 (Q4 2025), and $0.36 (Q3 2025).